N/A N=40 Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?
Chest Pain Atypical Syndrome
Primary: Mean Change in Esophageal Length With Acid — -0.40; -0.39 centimeters
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=211 Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
Acellular Pertussis · Poliomyelitis · Diphtheria
Primary: Number of Seroprotected Subjects Against Diphteria (D) and Tetanus (T) Antigens — 61; 66; 68; 63 Subjects
Phase 4 N=300 Nutrition, Physical Performance & Fitness in Indian School Children
Physical Fitness · Nutritional Status
Primary: Change From Baseline in Maximal Aerobic Capacity (VO2max)- 12 Inch Step Test After 4 Months — 36.8; 37.9; 37.0; 38.9 mL/kg/min. — p=0.004
Phase 4 N=60 CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity
Obesity · Laparoscopic Gastric Bypass Surgery · Surgical Conditions
Primary: Subjective Evaluation of the View on the Operating Field by the Surgeon — 4.2; 3.9 units on a scale — p=0.16
N/A N=66 Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
KERATOCONJUNCTIVITIS SICCA · XEROSTOMIA · SICCA SYNDROME
Primary: The Xerostomia Inventory — 40.2; 39.3 units on a scale — p=0.05
Phase 3 N=194 Clinical Trial to Reduce Drinking in Women With HIV
HIV Infection
Primary: Number of Participants Who Quit Hazardous Drinking — 44; 39 Participants — p=0.36
Phase 3 N=548 Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older
Epilepsy · Monotherapy
Primary: Number of Subjects With at Least One Treatment-emergent Adverse Event (AE) During the Treatment Phase (Maximum of 3.5 Years) — 181; 182 Participants
N/A N=70 Laser CO2 Versus TENS After Reconstruction of the Rotator Cuff
Rotator Cuff Injury
Primary: Visual Analogue Scale Mean Score — 1.40; 1.20 units on a scale
Phase 1 N=16 A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients
Advanced Malignant Solid Tumors
Primary: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUClast) For Dextromethorphan and Dextrorphan 3 Days Prior to PF-00299804 Dosing — 206.4; 2199…
Phase 2 N=54 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover
Rhinitis, Allergic, Seasonal
Primary: Weighted Mean TNSS (Sneeze, Itch, Rhinorrhoea and Nasal Blockage) 1-6 Hours Post Start of Allergen Challenge (2-7 Hours Post-dose) on Day 3 — 4.9; 4.2; 3.6; 3.5 Score on…
Phase 3 N=114 Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients
Anemia
Primary: Efficacy of HX575 in the Treatment of Chemotherapy Associated Anemia — 37; 15 Participants
N/A N=32 A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects
Erythema · Edema
Primary: Number of Subjects With Observed Local Erythema Based on the 5 Point Scoring Scale — 0 Participants
N/A N=9 Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms
Aneurysm of Aortic Arch
Primary: Number of Participants With Successful Study Device Access — 9 Participants
N/A N=40 Effectiveness Between Nutritional Counseling Monthly Phone Call Versus Self Help Informative Booklet
Obesity · Overweight
Primary: Weight Loss — 7.56; 2.80 percentage of weight loss
Phase 3 N=64 Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes
Type 2 Diabetes
Primary: Absolute Change in the Endothelial Progenitor Cell (EPC) Number — 37; 36; 45; 32 EPC/10^6 cells — p=<0.05